News

Borregaard ASA Reports Impressive Fourth Quarter Results

Borregaard ASA Reports Impressive Fourth Quarter Results

Financial Highlights from Borregaard ASA in the Fourth Quarter

Borregaard ASA showcased impressive operating revenues of NOK 1,744 million in the fourth quarter. This is a significant increase from NOK 1,605 million from the previous year, demonstrating robust growth and an effective business strategy. EBITDA reached NOK 398 million, up from NOK 327 million this time last year, marking a notable improvement in operational efficiency.

Sector Performance: BioSolutions, BioMaterials, and Fine Chemicals

The various sectors within Borregaard displayed mixed results. The BioSolutions segment reported increased sales, which was a primary driver for their strong performance during this period. In contrast, while BioMaterials maintained consistent results due to higher sales volume and a better product mix, it faced challenges from rising wood costs that affected margins.

Fine Chemicals, however, experienced a decline primarily due to lower delivery volumes, which impacted its overall results. Despite this, the currency fluctuations worked in Borregaard's favor, contributing positively to net currency effects.

Year-End Financial Performance: Setting Records

For the full year, Borregaard reported an impressive climb in operating revenues to NOK 7,617 million compared to NOK 7,132 million in the previous year. EBITDA for the year also hit an all-time high of NOK 1,874 million, surpassing last year’s NOK 1,781 million. While total profit before tax fell slightly to NOK 1,079 million compared to NOK 1,124 million in the preceding year, the earnings per share showed resilience, coming in at NOK 8.25 versus NOK 8.73 last year.

CEO’s Perspective on 2024 Results

President and CEO Per A. Sørlie expressed satisfaction with the company's performance. He stated, "We are pleased to report an all-time high result for 2024. Our specialisation strategy has proven resilient amid challenging macroeconomic and geopolitical conditions." This sentiment portrays the leadership's confidence in Borregaard's strategic direction and operational adaptability.

Insights into Costs and Challenges

The financial report also indicated that other income and expenses amounted to NOK -30 million, primarily attributed to the remediation of contaminated soil at the Sarpsborg site. This investment in maintaining operational integrity highlights the company's commitment to environmental responsibility, even amidst financial pressures.

What Lies Ahead for Borregaard ASA?

Looking ahead, Borregaard ASA remains focused on leveraging its unique strengths in speciality cellulose and sustainable solutions. The diverse portfolio is expected to mitigate the challenges posed by fluctuations in raw material costs, which are becoming increasingly significant in today’s market. As companies worldwide adapt to changing economic conditions, Borregaard's agility will be key to navigating these high-stakes environments.

Contact Information and Investor Relations

For further inquiries, stakeholders can reach out to the Director of Investor Relations, Knut-Harald Bakke at +47 905 79 164, or the Director of Communications, Tone Horvei Bredal at +47 924 67 711. Transparency and communication remain priorities for Borregaard as they pursue their growth strategies.

Frequently Asked Questions

What were the key financial results for Borregaard ASA in Q4 2024?

Borregaard ASA reported operating revenues of NOK 1,744 million and an EBITDA of NOK 398 million, showcasing significant year-over-year growth.

How did the different segments of Borregaard ASA perform?

The BioSolutions segment saw increased sales, while BioMaterials remained stable but faced rising wood costs. Fine Chemicals experienced a decline due to lower delivery volumes.

What was the full-year performance for Borregaard ASA?

In 2024, operating revenues increased to NOK 7,617 million, and EBITDA reached an all-time high of NOK 1,874 million, despite a slight dip in profit before tax.

Who can I contact for more information regarding Borregaard ASA?

For investor relations contact Knut-Harald Bakke at +47 905 79 164 or Tone Horvei Bredal at +47 924 67 711 for communication inquiries.

What strategies is Borregaard ASA employing to tackle future challenges?

Borregaard ASA is focusing on its specialisation strategy and diversifying its product offerings to mitigate risks associated with raw material cost fluctuations and global economic challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 140

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
WhiteHorse Set to Redeem Its 2028 Notes Completely

Updated Category News Views 104

WhiteHorse Finance Divests Its 7.875% Notes Well, WhiteHorse Finance is making some moves, folks. They're planning to redeem their 7.875% notes due in 2028, totaling a cool $34.5 million. This ain't just pocket change, especially with the way markets have been bobbing and weaving lately. The redemption is slated for December 15, 2026, when the notes will get delisted from...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 199

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 74

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 133

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 75

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 154

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

Chris Larsen's Strategic XRP Moves: Implications for Investors

Updated Category News Views 333

Overview of Chris Larsen's Recent XRP Transactions Chris Larsen, the influential co-founder and executive chairman of Ripple, has been actively transferring substantial amounts of XRP. Recently, he moved approximately $26 million worth of XRP to Coinbase, one of the most prominent cryptocurrency exchanges. This transfer is part of a larger pattern, contributing to an...

Continue Reading
Mastercard's Options Activity Insights: Market Trends Explored

Updated Category News Views 143

Understanding Mastercard's Recent Options Activity Mastercard is currently in the spotlight as investors engage in noteworthy bearish actions. This indicates a prevailing sentiment among wealthy clients regarding their perspective on the financial giant. Investor Insights on Mastercard Our analysis indicates that certain trades of interest have emerged in the options...

Continue Reading
Discover How CryptoGO Revolutionizes Memecoin Trading

Updated Category News Views 222

Transforming Memecoin Trading for Beginners CryptoGO is a innovative Telegram mini-app crafted specifically to ease the entry of newcomers into the world of memecoin trading. By harnessing the power of the Solana blockchain, CryptoGO revolutionizes how users engage with meme tokens, making the process both accessible and enjoyable. With support for fiat currency, users...

Continue Reading
Pyxis Oncology Updates on Financial Status and Future Plans

Updated Category News Views 325

Latest Developments at Pyxis Oncology Pyxis Oncology, Inc. has recently made headlines with its remarkable progress in the field of oncology. The development and ongoing trials of their innovative therapy, micvotabart pelidotin (MICVO), have shown encouraging preclinical results, highlighting its unique three-pronged mechanism of action. This mechanism enhances anti-tumor...

Continue Reading
Florida’s Cannabis Legalization Gains Momentum with Herald Support

Updated Category News Views 93

Support for Cannabis Legalization Gains Traction The Miami Herald, a notable publication in Florida with a rich history dating back to 1903, has come out strongly in favor of the state's cannabis legalization initiative known as Amendment 3. The proposal will be presented to voters in the upcoming election, marking a significant shift in public policy towards cannabis....

Continue Reading